Cognition Therapeutics Inc
Research Cognition Therapeutics Inc (CGTX) on Bullrun: market cap USD 97.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCGTX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 97.91M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 3.93M
- Free cash flow-USD 3.07M
Valuation Snapshot
latest market cap is USD 97.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 23.49M | -USD 24.59M | n/a | -0.32 | USD 36.81M | USD 638.00K | USD 34.27M |
| FY2024 | USD 0 | -USD 33.97M | -USD 28.48M | n/a | -0.86 | USD 25.01M | USD 814.00K | USD 18.75M |
| FY2023 | n/a | -USD 25.79M | -USD 16.17M | n/a | -0.86 | USD 29.92M | USD 1.24M | USD 24.47M |
| FY2022 | n/a | -USD 21.40M | -USD 18.70M | n/a | -0.91 | USD 41.56M | USD 967.00K | USD 40.25M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 97.91M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 120.02M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 41.90M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 59.43M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 60.88M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 140.49M | n/a | n/a | n/a |
About Cognition Therapeutics Inc
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
Related stock research
Other Healthcare stocks
Adicet Bio Inc (1IJ)
Cartesian Therapeutics, Inc. (1S70)
QUOIN PHARMACEUT.ADR5000 (2EB0)
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Frequently asked questions
What is Cognition Therapeutics Inc's market cap?
Cognition Therapeutics Inc's market capitalization is USD 97.91M.
What does Cognition Therapeutics Inc do?
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.